Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Erector spinae plane block for pain after laparoscopic abdominal surgery

Official title: Efficacy of Erector Spinae Plane Block on Postoperative Analgesia in Patients Undergoing Laparoscopic Abdominal Surgeries

Run by Assiut University · NCT07272577 · Data updated 2026-11-12

This will test whether giving an erector spinae plane block reduces pain and 24-hour opioid use for adults having laparoscopic abdominal surgery.

More Postoperative Analgesia trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment50 (estimated)
SponsorAssiut University
Academic / other
Locations1 site (Asyut)
StatusRecruiting
StartedDecember 10, 2025
Main results expectedApril 1, 2026
Study endsApril 1, 2026
Registry record updatedDecember 11, 2025
Trial IDNCT07272577 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 18 or older with ASA physical status I–II and BMI 20–30 kg/m2 who are scheduled for laparoscopic abdominal surgery under general anesthesia would be eligible.

Probably not a fit

Patients with bleeding or coagulation disorders, local sepsis, peripheral neuropathies, chronic pain or opioid dependency, contraindications to regional anesthesia, hypertension, or uncontrolled diabetes would not be eligible and therefore would not receive benefit from enrollment.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional study delivers an erector spinae plane block (ESPB) to adult patients undergoing laparoscopic abdominal procedures under general anesthesia and measures postoperative analgesia. Pain scores and opioid consumption over the first 24 hours after surgery will be recorded to compare analgesic effectiveness. The protocol enrolls ASA I–II adults with BMI 20–30 kg/m2 and excludes patients with bleeding disorders, local sepsis, chronic pain, opioid dependence, or other contraindications to regional anesthesia. Outcomes will be used to determine whether ESPB provides improved postoperative pain control in this surgical population.

Why it matters

Potential benefit: If successful, this approach could reduce postoperative pain and opioid use, helping patients recover faster and potentially shorten hospital stays.

How similar studies have gone: ESPB has previously reduced 24-hour opioid consumption and improved analgesia in breast, video-assisted thoracoscopic, and cardiothoracic surgeries, though its benefit specifically for laparoscopic abdominal procedures is less established.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age ≥ 18 years.
* Both sexes.
* American Society of Anesthesiologists (ASA) physical status I-II.
* Body mass index (BMI) between 20-30 kg/m2.
* Patients undergoing laparoscopic abdominal surgeries under general anesthesia.

Exclusion Criteria:

* Bleeding or coagulation disorders.
* Having local sepsis, pre-existing.
* Peripheral neuropathies.
* Chronic pain conditions.
* Having any contraindication to regional anesthesia administration.
* Opioid dependency.
* Hypertension.
* Uncontrolled diabetes mellitus.

Where it's running

  • Assiut University
    Asyut, Egypt
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.